WTIP

WTIP is an Ajuba-family LIM-domain scaffold protein that functions as a tension-sensitive adaptor at cell–cell junctions, coordinating actomyosin contractility, Hippo pathway signaling, miRNA-mediated gene silencing, and transcriptional regulation across multiple tissues including podocytes, neuroepithelium, and cardiomyocytes. At adherens junctions and focal adhesions, WTIP directly binds the RhoA-GEF ARHGEF12 to promote RhoA/ROCK-dependent stress fiber formation and interacts with Shroom3 to regulate apical constriction during neural tube closure (PMID:21900451, PMID:29661847, PMID:35862649). WTIP suppresses Hippo signaling by linking nephrin/Nck complexes to Lats1, sequestering it from activation; upon injury-induced nephrin dephosphorylation, Lats1 is released and activated, leading to YAP downregulation (PMID:27033705, PMID:36439396). WTIP also localizes to P-bodies where it bridges Ago1/2 to the eIF4E–m7GTP cap complex to enable miRNA-mediated translational silencing, undergoes JNK/dynein/microtubule-dependent nuclear translocation upon injury to modulate transcription factors including WT1 and FOXO3a, and inhibits AKT activity through PP2A recruitment (PMID:20616046, PMID:20086015, PMID:34930905, PMID:40279682).

1. 2009 Medium

   Establishing that WTIP is a Ror2-interacting protein that inhibits canonical Wnt signaling resolved the question of whether LIM-domain proteins at cell junctions could participate in Wnt pathway modulation.

   Evidence Co-immunoprecipitation and Xenopus Wnt reporter assay showing WTIP–Ror2 interaction and functional Wnt inhibition

   PMID:19785987

   Open questions at the time

   • Single Co-IP without reciprocal validation
   • Endogenous interaction not confirmed
   • Downstream targets of WTIP-mediated Wnt inhibition not identified
2. 2010 High

   Two contemporaneous studies established dual compartmentalization of WTIP: it localizes to P-bodies where it bridges Ago1/2 to the eIF4E–m7GTP cap for miRNA silencing, and it undergoes JNK/dynein/microtubule-dependent nuclear translocation from cell contacts upon injury, revealing stimulus-dependent shuttling as a core WTIP mechanism.

   Evidence Co-IP with cap-binding assays and knockdown reporter silencing for P-body function; live imaging, subcellular fractionation, and pharmacological inhibition for nuclear translocation

   PMID:20086015 PMID:20616046

   Open questions at the time

   • Whether P-body function and nuclear translocation are independently regulated is unclear
   • Direct RNA targets of WTIP-dependent miRNA silencing not identified
   • Nuclear transcriptional targets upon injury-induced translocation not fully defined
3. 2011 High

   Identification of ARHGEF12 as a direct WTIP partner established the mechanism by which WTIP promotes RhoA/ROCK-dependent actin stress fiber formation at focal adhesions and adherens junctions, answering how a LIM scaffold controls actomyosin contractility.

   Evidence Co-IP, shRNA knockdown, overexpression, and pharmacological inhibition with C3 toxin and ROCK inhibitor in podocytes

   PMID:21900451

   Open questions at the time

   • Structural basis of WTIP–ARHGEF12 interaction not resolved
   • Whether WTIP activates or scaffolds ARHGEF12 catalytic activity is unknown
4. 2012 Medium

   Zebrafish studies revealed WTIP functions in planar cell polarity, controlling mitotic spindle orientation and ciliogenesis through genetic interaction with Vangl2, extending WTIP's role beyond cell junctions to basal body/cilium biology.

   Evidence Morpholino knockdown in zebrafish, double morphant epistasis with Vangl2, high-speed video microscopy of cilia motility

   PMID:23213452

   Open questions at the time

   • Morpholino-only approach without genetic mutant confirmation
   • Direct biochemical connection between WTIP and Vangl2 not established
   • Mechanism of WTIP at the basal body not defined
5. 2013 Medium

   Discovery that dendrin interacts with WTIP at the podocyte slit diaphragm and relocalizes to the nucleus upon injury added another injury-responsive WTIP partner, suggesting coordinated nuclear signaling from the slit diaphragm complex.

   Evidence Yeast two-hybrid and co-immunoprecipitation, immunofluorescence in adriamycin nephropathy model

   PMID:24376653

   Open questions at the time

   • Functional consequence of dendrin–WTIP interaction not tested
   • No reciprocal Co-IP reported
   • Whether dendrin and WTIP co-translocate to the nucleus is unknown
6. 2014 Medium

   Demonstration that WTIP represses ASXL2-mediated retinoic acid signaling expanded WTIP's nuclear functions to include transcriptional corepression of chromatin regulatory complexes.

   Evidence Yeast two-hybrid, co-immunoprecipitation, luciferase reporter assay in HeLa cells

   PMID:25065743

   Open questions at the time

   • Single Co-IP without domain mapping for ASXL2 interaction
   • Endogenous relevance in podocytes or other tissues not tested
   • Mechanism of repression (recruitment of corepressors?) not defined
7. 2015 Medium

   Asxl1 knockout mice showing kidney and podocyte defects with upregulated Wt1/Wtip targets provided in vivo genetic evidence that ASXL1–WTIP interaction maintains podocyte structure.

   Evidence Co-immunoprecipitation, Asxl1 knockout mouse, gene expression analysis

   PMID:26385183

   Open questions at the time

   • WTIP was not directly knocked out in this model
   • Whether WTIP is the mediating partner versus other ASXL1 targets is unresolved
8. 2016 High

   Three parallel discoveries established WTIP as a node connecting nephrin signaling to Hippo pathway suppression (via Lats1 sequestration), cooperating with Prickle3 for basal body organization, and localizing to basal bodies in the proepicardial organ for cardiac left-right patterning.

   Evidence Nephrin mutational analysis with Co-IP and in vivo LPS model for Hippo; Pk3 Co-IP and Xenopus GRP morpholino epistasis for ciliogenesis; zebrafish morpholino KD with immunofluorescence for cardiac laterality

   PMID:27033705 PMID:27062996 PMID:27484451

   Open questions at the time

   • Direct measurement of WTIP effect on Lats1 kinase activity in vitro is lacking
   • Whether Pk3–WTIP and nephrin–WTIP complexes overlap in vivo is unknown
   • Role of WTIP in proepicardial specification versus cilia function not separated
9. 2016 Medium

   Identification of WTIP–BRCA2 interaction and requirement of WTIP for BRCA2 centrosome localization revealed an unexpected role in centrosome function and mitotic fidelity.

   Evidence Yeast two-hybrid, Co-IP, GST pull-down, shRNA knockdown with immunofluorescence in HeLa cells

   PMID:27535760

   Open questions at the time

   • Single lab finding not independently replicated
   • Whether WTIP scaffolds BRCA2 at centrosomes or regulates its transport is unclear
   • Relationship to WTIP's basal body localization not explored
10. 2018 High

    Live imaging in Xenopus showed WTIP adopts tension-sensitive distributions at apical junctions dependent on myosin II and physically associates with Shroom3 to regulate apical constriction during neural tube closure, establishing WTIP as a mechanosensitive regulator of morphogenesis.

    Evidence Morpholino knockdown in Xenopus, fluorescent protein tagging/live imaging, Co-IP, dominant-negative C-terminal fragment assay

    PMID:29661847

    Open questions at the time

    • Whether tension sensing involves conformational unfolding of LIM domains is not tested
    • How WTIP coordinates Shroom3 and ARHGEF12 simultaneously is unresolved
11. 2018 Medium

    Discovery of a UBA2-WTIP fusion in AML that abrogates P-body formation and activates STAT3/5 and ERK1/2 demonstrated pathological consequences of disrupting WTIP's scaffold functions, linking WTIP loss-of-function to oncogenic signaling.

    Evidence RT-PCR/Sanger sequencing, ectopic expression in KG-1a cells, immunofluorescence for P-bodies, immunoblot, xenograft

    PMID:30179602

    Open questions at the time

    • Single patient fusion; frequency in AML cohorts not established
    • Whether STAT/ERK activation is direct or secondary to P-body loss is unclear
12. 2021 Medium

    Two studies expanded WTIP's functional network: WTIP transcriptionally activates FOXO3a to induce PUMA-mediated apoptosis in AML, and the N-terminus of WTIP associates with centriolar satellite protein SSX2IP for neural tube closure, revealing both nuclear transcriptional and centrosomal functions.

    Evidence Co-IP plus luciferase reporter plus in vivo xenograft for FOXO3a; proximity biotinylation, Co-IP, and double morpholino knockdown in Xenopus for SSX2IP

    PMID:34710136 PMID:34930905

    Open questions at the time

    • Whether WTIP binds the FOXO3a promoter directly or through a cofactor is unresolved
    • SSX2IP–WTIP interaction confirmed only by proximity biotinylation/Co-IP without endogenous validation
13. 2022 Medium

    Overexpression studies showed WTIP competes with LIMD1 at junctions and paradoxically promotes YAP phosphorylation (pro-Hippo effect), refining the model that WTIP cannot efficiently recruit Lats kinases like other Ajuba members, while domain mapping confirmed high-affinity WTIP–ARHGEF12 binding through LIM and PDZ domains. A hypertrophic cardiomyopathy–associated WTIP p.Y233F variant disrupts Wnt protein binding and alters cardiomyocyte calcium dynamics.

    Evidence Overexpression in MCF10A cells with phospho-YAP immunoblot; Co-IP domain mapping with heterozygous mouse injury model; shRNA in NRVMs, patient iPSC-CMs, and zebrafish morpholino for HCM variant

    PMID:35671065 PMID:35862649 PMID:36439396

    Open questions at the time

    • WTIP-specific Hippo signaling output versus LIMD1 compensation not tested endogenously
    • Structural basis for failure to recruit Lats kinases not determined
    • HCM mechanism linking Y233F to calcium handling is incompletely defined
14. 2025 Medium

    Discovery that WTIP recruits PP2A to inhibit AKT T308 phosphorylation established a new mechanism by which WTIP suppresses stemness and chemoresistance, with TET2/PATZ1 identified as upstream transcriptional activators of WTIP expression.

    Evidence Co-IP (WTIP–PP2A), AKT kinase assay, overexpression/knockdown, TET2/PATZ1 reporter assay in gastric cancer cells

    PMID:40279682

    Open questions at the time

    • Single lab finding not yet independently replicated
    • Whether PP2A interaction occurs at junctions or in the cytosol is unclear
    • Relevance of TET2/PATZ1 axis to non-cancer WTIP biology not tested

• Major unresolved questions include: (1) how WTIP integrates its junctional, centrosomal, P-body, and nuclear functions in a single cell; (2) whether LIM domain conformational changes mediate tension sensing; (3) the structural basis distinguishing WTIP from LIMD1/Ajuba in Hippo signaling; and (4) whether WTIP mutations are causative for human kidney or cardiac disease.
• No crystal or cryo-EM structure of WTIP or its complexes
• No WTIP conditional knockout mouse phenotype reported
• Disease causality for human WTIP variants not established by family segregation or rescue